Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

KETOROLAC TROMETHAMINE

Active
SPE2DP-26-T-4143Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Ketorolac Tromethamine Injection, USP 15 mg per mL in prefilled syringes, 24’s per unit, is being procured under contract SPE2DP-26-T-4143 for delivery to Fort Bragg, North Carolina, with a required delivery date of July 13, 2026, and a five-day delivery window. The item is identified by NSN 6505-01-666-2156 and NDC 76045-0107-10, manufactured by FRESENIUS KABI, LLC, and must comply with DLA’s Master List of Technical and Quality Requirements, including Packaging Requirement RP001 and Shelf-life requirement RS016, which mandates a non-extendable 24-month shelf life. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and units must be sealed in commercial containers that ensure protection from damage during transit. The product must be shipped by the fastest traceable means, excluding parcel post, and labeled according to current Hazard Communication Standards (29 C.F.R. 1910.1200), including OSHA-compliant Safety Data Sheets and labels, as mandated post-June 2015. The quantity is one unit of issue (PG), with zero variance permitted, and inspection and acceptance occur at the destination. Packaging and palletization must follow DLA specifications, and government identification must not appear on non-accepted supplies. The contract requires full compliance with all applicable DLA technical and quality requirements, which take precedence over ASTM D3951 or other general commercial standards.

General Info

Ketorolac injection, 15 mg/mL, 24’s per unit, DLA contract, delivery by July 13, 2026, 24-month shelf life, OSHA-compliant labeling.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4143.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
KETOROLAC TROMETHAMINE INJECTION
KETOROLAC TROMETHAMINE INJECTION, USP 15 MG PER ML, PREF-FILLED SYRINGE,
24'S U/I-PG (24'S)
MARK IN ACCORDANCE WITH MMS No. 1B 30 March 2017 RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of
SPE2DP-26-T-4143
SECTION B
Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
https://www.osha.gov/law-regs.html
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
FRESENIUS KABI, LLC 57KZ6 P/N NDC76045-0107-10
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017436230 0001 PG 1.000
NSN/MATERIAL:6505016662156
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
SPE2DP-26-T-4143
SECTION B
PR: 7017436230 PRLI: 0001 CONT’D
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF261890018
RDD: 203
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/13/2026
SPE2DP-26-T-4143
SECTION B
PR: 7017436230 PRLI: 0001 CONT’D
SPE2DP-26-T-4143 NSN/Part Number: 6505-01-666-2156 Quantity: 1 PG Purchase Request: 7017436230QTY: 1 Delivery: 5 days ADO

Similar Contracts

NAICS: 325411
New
DIBBS
ANALGESIC GEL, TOPICALThe contract specifies the procurement of an analgesic gel for topical use containing 5% menthol USP, supplied in 4 oz tubes with 144 tubes per case, classified as a flammable hazardous material requiring storage at 20–25°C (68–77°F) and protection from excessive heat or open flame. The item is identified by NSN 6505-01-658-7643 with a non-extendable shelf life of 24 months and must be packaged in commercial-grade containers that ensure protection from damage during transport, conforming to Medical Marking Standard No. 1 instead of MIL-STD-129. Shipment of the product must adhere to applicable hazard communication regulations, including the submission of Safety Data Sheets compliant with 29 C.F.R. 1910.1200 prior to award, and each shipment must include an accompanying SDS. Labels must meet OSHA’s revised Hazard Communication Standard aligned with the Globally Harmonized System, and supplier employees must be trained on these requirements. Packaging and transportation must comply with 49 CFR and ICAO regulations due to the flammable nature of the product, and all materials must be marked and documented in accordance with DLA’s hazardous material protocols, including electronic submission of SDS to DLA.MSDS@DLA.MIL. The contract is issued under solicitation SPE2DP-26-T-4115, requiring delivery within 20 days to Waterveciet, NY, and is managed by the Department of Defense’s Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOLBenzocaine and Menthol Lozenge, manufactured by RB Health US LLC and Reckitt Benckiser LLC, is a 15 mg benzocaine and 2.6 mg menthol oral pain reliever in honey lemon flavor, packaged in units of 16 lozenges, with a shelf life of 36 months that is non-extendable. The product must be stored at 20-25°C (68-77°F) and protected from humidity. All medical acquisitions require commercial packaging that ensures protection from damage or breakage, with each unit sealed in an appropriate container and shipped in exterior containers that guarantee safe, low-cost delivery to the destination. Material must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging must comply with DLA’s packaging requirements and palletization standards. The item is identified by NSN 6505017081449 and NDC 63824-0732-16, and is procured across five contract line items totaling 58 package units, each priced at $1.00 per unit, for total contract value of $58.00. Delivery is required within 20 days, FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring at the delivery point. Shipments must be traceable, excluding parcel post, and sent to designated military logistics addresses at Fort Bragg, North Carolina, and Fort Stewart, Georgia. The solicitation, issued by the Department of Defense under contract SPE2DP-26-T-4113, has a response deadline of July 20, 2026, and requires compliance with all technical and quality requirements listed in the DLA Master List.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details